Drug profile · INN
guanethidine monosulfate
GUANETHIDINE MONOSULFATE
guanethidine monosulfate (GUANETHIDINE MONOSULFATE) is a norepinephrine transporter substrate. Route of administration: oral. Current US regulatory status: approved.
Drug details — guanethidine monosulfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
guanethidine monosulfate (GUANETHIDINE MONOSULFATE) is a norepinephrine transporter substrate. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter substrate
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is guanethidine monosulfate?
guanethidine monosulfate (GUANETHIDINE MONOSULFATE) is a norepinephrine transporter substrate. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for guanethidine monosulfate?
GUANETHIDINE MONOSULFATE is a marketed brand name for guanethidine monosulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of guanethidine monosulfate?
guanethidine monosulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.